Medical Food for the Dietary Management of Metastatic Colorectal Cancer
Recruiting in Palo Alto (17 mi)
+6 other locations
Overseen byAndrea Cerceck, MD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Faeth Therapeutics
No Placebo Group
Trial Summary
What is the purpose of this trial?This trial is testing a special diet that limits certain building blocks of proteins in patients with advanced colorectal cancer. The goal is to see if this diet can help manage the disease by restricting nutrients that cancer cells need to grow. Early results indicate that this diet is safe and feasible for treating patients with advanced cancer.
Eligibility Criteria
Inclusion Criteria
ECOG Performance Status of ≤ 1.
Subject is not receiving any other cancer therapy. Subjects participating in surveys or observational studies are allowed.
Has failed treatment for fluoropyrimidine and oxaliplatin ± BEV.
+15 more
Exclusion Criteria
More than one prior chemotherapy regimen administered in the metastatic setting.
Major surgery within 6 weeks prior to randomization.
Current brain metastasis.
+32 more
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Experimental: Nonessential Amino Acid Restriction (NEAAR) Medical FoodExperimental Treatment1 Intervention
All subjects will receive NEAAR medical food
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
University of Arizona Cancer CenterTucson, AZ
Pacific Cancer Medical CenterAnaheim, CA
Cedars-Sinai Health SystemBeverly Hills, CA
Hoag Memorial Hospital PresbyterianNewport Beach, CA
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
Faeth TherapeuticsLead Sponsor